Inspiratory Muscle Strength Training in Adults With Type 2 Diabetes
DIT
Effects of Inspiratory Muscle Strength Training on Metabolic and Cardiovascular Health in Adults With Type 2 Diabetes
1 other identifier
interventional
11
1 country
1
Brief Summary
This clinical research study will investigate the effects of 6 weeks of inspiratory muscle strength training on metabolic and cardiovascular outcomes in adults with recent-onset type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus-type-2
Started Jun 2023
Shorter than P25 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2022
CompletedFirst Posted
Study publicly available on registry
December 9, 2022
CompletedStudy Start
First participant enrolled
June 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2024
CompletedJune 14, 2024
June 1, 2024
10 months
November 30, 2022
June 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change from baseline fasting blood plasma glucose after 6 weeks of IMST
A blood sample will be collected after 12 hours of fasting. Blood and plasma will be separated and plasma glucose levels will be quantified.
Blood plasma collected and analyzed at baseline and after 6 weeks of training
Change from baseline fasting blood plasma Insulin after 6 weeks of IMST
A blood sample will be collected after 12 hours of fasting. Blood and plasma will be separated and plasma insulin levels will be quantified.
Blood plasma collected and analyzed at baseline and after 6 weeks of training
Change from baseline insulin sensitivity after 6 weeks of IMST
A blood sample will be collected after 12 hours of fasting. Insulin sensitivity will be calculated using the homeostatic model assessment of insulin resistance (HOMA-IR): (fasting serum insulin (mU/L) × fasting plasma glucose (mmol/L) × 22.5).
Blood plasma collected and analyzed at baseline and after 6 weeks of training
Secondary Outcomes (2)
Change from baseline systolic blood pressure after 6 weeks of IMST
Blood pressure will be assessed at baseline and after 6 weeks of training
Change from baseline Nitric Oxide-mediated Endothelial Dependent Dilation (EDD)
EDD will be assessed at baseline and after 6 weeks of training
Other Outcomes (1)
Change from baseline proteomic analysis
Proteomics will be performed at baseline and after 6 weeks of training
Study Arms (2)
High-resistance IMST
EXPERIMENTAL30 breaths/day (5 sets of 6 breaths, one minute of rest between sets), 5 days/week, 6 weeks
Low-resistance IMST
ACTIVE COMPARATOR30 breaths/day (5 sets of 6 breaths, one minute of rest between sets), 5 days/week, 6 weeks
Interventions
30 breaths/day, 5 days/week, 6 weeks
Eligibility Criteria
You may qualify if:
- diagnosed with type 2 diabetes by physician
- fasting plasma glucose levels ≥126 mg/dl and ≤240 mg/dl
- systolic blood pressure between 120-169 mmHg
- stable dose of medication (three months on the same dose)
- weight stable in the prior 3 months (\<3.0 kg weight change) and willing to remain weight stable throughout the study
- absence of unstable clinical disease as determined by medical history
You may not qualify if:
- current smoker (including tobacco products, vaping devices, THC, etc…)
- have an uncontrolled medical condition (e.g., cancer)
- myocardial infarction or stroke within the previous 12 months
- performs regular aerobic exercise (\>4 bouts/week)
- BMI ≥ 40 kg/m2
- systolic blood pressure \<120 or ≥170 mmHg
- diastolic blood pressure \>100 or \<60 mmHg
- Cheyne-Stokes respiration
- history of perforated eardrum
- history of glaucoma or retinopathy
- history of collapsed lung
- diagnosed with asthma
- pregnant, breastfeeding, or trying to become pregnant (self-reported)
- medications that, in the opinion of the study physician or nurse practitioner, may impact the outcomes of the study (e.g., steroids)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arizona Respiratory and Neurophysiology Laboratory
Tucson, Arizona, 85724, United States
Related Publications (1)
Craighead DH, Tavoian D, Freeberg KA, Mazzone JL, Vranish JR, DeLucia CM, Seals DR, Bailey EF. A multi-trial, retrospective analysis of the antihypertensive effects of high-resistance, low-volume inspiratory muscle strength training. J Appl Physiol (1985). 2022 Oct 1;133(4):1001-1010. doi: 10.1152/japplphysiol.00425.2022. Epub 2022 Sep 15.
PMID: 36107991BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dallin Tavoian, PhD
University of Arizona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- This is a randomized trial and participants will be blinded to their allocation group.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2022
First Posted
December 9, 2022
Study Start
June 30, 2023
Primary Completion
May 6, 2024
Study Completion
May 6, 2024
Last Updated
June 14, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make IPD available